Tamás Masszi

335 total papers · 16.5k total citations
187 papers, 6.1k citations indexed

About

Tamás Masszi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tamás Masszi has authored 187 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Hematology, 66 papers in Genetics and 56 papers in Molecular Biology. Recurrent topics in Tamás Masszi's work include Multiple Myeloma Research and Treatments (64 papers), Chronic Myeloid Leukemia Treatments (42 papers) and Chronic Lymphocytic Leukemia Research (31 papers). Tamás Masszi is often cited by papers focused on Multiple Myeloma Research and Treatments (64 papers), Chronic Myeloid Leukemia Treatments (42 papers) and Chronic Lymphocytic Leukemia Research (31 papers). Tamás Masszi collaborates with scholars based in Hungary, United States and Italy. Tamás Masszi's co-authors include Ivan Špıčka, Antonio Palumbo, María‐Victoria Mateos, William Deraedt, Andrew Spencer, Alessandro M. Vannucchi, Katja Weisel, Claire Harrison, Jan Walewski and Ajay K. Nooka and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Tamás Masszi

178 papers receiving 5.9k citations

Hit Papers

normalize citations (0→100%) normalize lifespan (0→100%) sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

2016 1.0k citations Antonio Palumbo, Asher Chanan‐Khan et al. New England Journal of Medicine profile →
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

2015 592 citations Alessandro M. Vannucchi, Jean‐Jacques Kiladjian et al. New England Journal of Medicine profile →
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

2015 474 citations Craig H. Moskowitz, Auayporn Nademanee et al. The Lancet profile →
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study

2015 380 citations Owen A. O’Connor, Steven M. Horwitz et al. Journal of Clinical Oncology profile →
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

2015 337 citations Animesh Pardanani, Claire Harrison et al. JAMA Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Tamás Masszi	3.8k	2.3k	2.3k	2.3k	1.1k	187	6.1k
Sigurður Y. Kristinsson	3.8k 1.0×	1.6k 0.7×	2.6k 1.1×	2.2k 1.0×	826 0.7×	142	6.0k
Haifa Kathrin Al‐Ali	3.2k 0.8×	820 0.4×	3.2k 1.4×	1.7k 0.7×	750 0.7×	166	4.9k
Uday Popat	4.0k 1.0×	1.9k 0.8×	1.5k 0.7×	1.3k 0.6×	969 0.9×	396	6.5k
Javier Pinilla‐Ibarz	2.6k 0.7×	1.8k 0.8×	2.3k 1.0×	1.9k 0.8×	767 0.7×	234	5.8k
Miloslav Beran	3.3k 0.9×	1.1k 0.5×	2.6k 1.1×	2.0k 0.9×	1.1k 1.0×	106	5.6k
Sa A. Wang	3.1k 0.8×	1.2k 0.5×	1.8k 0.8×	934 0.4×	1.2k 1.1×	278	5.3k
Taghi Manshouri	3.1k 0.8×	1.3k 0.5×	3.1k 1.4×	3.0k 1.3×	739 0.7×	142	6.2k
Dieter K. Hossfeld	1.9k 0.5×	1.8k 0.8×	1.4k 0.6×	2.6k 1.1×	1.2k 1.1×	165	6.1k
Ashraf Badros	4.4k 1.1×	3.5k 1.5×	1.1k 0.5×	3.3k 1.5×	677 0.6×	173	7.1k
Ulrike Bacher	4.2k 1.1×	1.1k 0.5×	2.1k 0.9×	1.8k 0.8×	624 0.6×	280	5.7k

Countries citing papers authored by Tamás Masszi

Since Specialization

Citations

This map shows the geographic impact of Tamás Masszi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamás Masszi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamás Masszi more than expected).

Fields of papers citing papers by Tamás Masszi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamás Masszi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamás Masszi. The network helps show where Tamás Masszi may publish in the future.

Co-authorship network of co-authors of Tamás Masszi

This figure shows the co-authorship network connecting the top 25 collaborators of Tamás Masszi. A scholar is included among the top collaborators of Tamás Masszi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamás Masszi. Tamás Masszi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact